Revelation Biosciences, INC.
SEC CIK 1810560 · REVB · last insider filing 2026-05-01
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Rolke James | Director · Chief Executive Officer | filed 2022 - 2026 |
| Roper Jess | Director | filed 2022 - 2026 |
| Chawla Lakhmir S | Director | filed 2023 - 2026 |
| Carver Jennifer | Director | filed 2022 - 2026 |
| Tidmarsh George F | Director | filed 2022 - 2025 |
| Labelle Curt H | Director | filed 2022 - 2023 |
| Carson William Howard | Director | filed 2021 - 2021 |
| Typaldos Andreas | Director · Chief Executive Officer | filed 2020 - 2020 |
| Fitzpatrick Sean H | Director · Chief Financial Officer | filed 2020 - 2020 |
| Hayes Anthony | Director | filed 2020 - 2020 |
| Dobkin David | Director | filed 2020 - 2020 |
| Dennis Barry | Director | filed 2020 - 2020 |
| Nicholson Robert D | Director | filed 2020 - 2020 |
| Angelides Kimon | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Zygmont Chester Stanley III | Chief Financial Officer | filed 2022 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.